Cerus reported $20.74M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Atrion ATRI:US 8.01M 1.09M
Cerulean Pharma CERU:US $ 2.59M 168.34K
Cerus CERS:US $ 20.74M 1.27M
Cytori Therapeutics CYTX:US $ 2.14M 99K
GRIFOLS GRF:SM 249.86M 7.28M
Haemonetics HAE:US $ 85.56M 7.69M
Meridian Bioscience VIVO:US $ 26.07M 3.67M
Nuvasive NUVA:US $ 160.28M 397K
Orasure Technologies OSUR:US $ 31.87M 4.31M
Quidel QDEL:US $ 89.9M 11.19M
Sientra SIEN:US 25.8M 3.24M
Staar Surgical STAA:US $ 29.21M 674K
Terumo 4543:JP 67.15B 3.63B
Utah Medical Products UTMD:US 2.85M 81K